Public Comment
ASTRO posts drafts of clinical practice guidelines, white papers and other documents for public comment before they are finalized and sent to ASTRO's Board of Directors for approval. The public comment period is an integral part of guidance development and is preceded by a series of reviews and revisions and may be followed by a final peer review if the document is submitted to a journal for publication. ASTRO encourages those in the radiation oncology field to comment and then share with colleagues, producing a more robust public response.
ASTRO seeks public comments for updated guideline on Hypofractionated Radiation Therapy for Localized Prostate Cancer
ASTRO requests feedback on a draft guideline on Hypofractionated Radiation Therapy for Localized Prostate Cancer. The guideline covers a broad scope of patients with localized prostate cancer receiving external beam radiation therapy as primary local therapy, including patients with low-risk prostate cancer who decline active surveillance and those with intermediate-, high- or very high-risk prostate cancer. Please review the guideline and submit comments through the webform by Wednesday, March 25. You can also access the draft guideline and webform at www.astro.org/PublicComment.
ASTRO requests feedback on a draft guideline on Hypofractionated Radiation Therapy for Localized Prostate Cancer. The guideline covers a broad scope of patients with localized prostate cancer receiving external beam radiation therapy as primary local therapy, including patients with low-risk prostate cancer who decline active surveillance and those with intermediate-, high- or very high-risk prostate cancer. Please review the guideline and submit comments through the webform by Wednesday, March 25. You can also access the draft guideline and webform at www.astro.org/PublicComment.
